Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Program

Merrill P.T., Clark W.L., Banker A.S., Fardeau C., Franco P., LeHoang P., Ohno S., Rathinam S.R., Ali Y., Mudumba S., Shams N., Nguyen Q.D., Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Study Group

2020
Ophthalmology

View publication

Therapeutic Area

Back of the eye (BOTE)
Categories

Clinical development

Affiliations

Department of Ophthalmology, Rush University Medical Center, Chicago, IL, United States; Department of Ophthalmology, Palmetto Retina Center, LLC, West Columbia, SC, United States; Banker's Retina Clinic and Laser Center, Navrangpura, Ahmedabad, India; Department of Ophthalmology, Pitie-Salpetriere Hospital, Sorbonne University, Paris, France; Organización Médica de Investigación, Buenos Aires, Argentina; Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan; Department of Uveitis Services, Aravind Eye Hospital, Madurai, Tamil Nadu, India; Ribomic USA Inc., Berkeley, CA, United States; Global Biomedical Strategy and Research, Santen, Inc., Emeryville, CA, United States; Global Research and Development, Santen, Inc., Emeryville, CA, United States; Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA, United States

Related Publications

Efficacy and Safety of Low-Concentration Atropine in Slowing Myopia Progression in Children in Japan: The Randomized, Double-Blind Phase II/III ORANGE Study

Ohno-Matsui K., Igarashi-Yokoi T., Migita Y., Yamakawa Y, on behalf of the ORANGE study investigators

Awareness of Myopia Associated Complications and Perspectives on Myopia Management Among Parents of Children with Myopia in France and the UK

Hafizi R., Deferne N., Paudel N., Angerer A., Hsieh H.-T.

Cutamesine (SA4503) Protects Retinal Ganglion Cells in an Ocular Hypertension Model of Glaucoma Determined Using Detection of Apoptosing Retinal Cells Technology and RBPMS Cell Marker

Sharif N.A., Takashi O., Taniguchi T., Sasaoka M., Guo L., Choi S., Luong V., Cordeiro M.F.